These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 12718877

  • 1. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.
    Baudino TA, Maclean KH, Brennan J, Parganas E, Yang C, Aslanian A, Lees JA, Sherr CJ, Roussel MF, Cleveland JL.
    Mol Cell; 2003 Apr; 11(4):905-14. PubMed ID: 12718877
    [Abstract] [Full Text] [Related]

  • 2. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
    Eischen CM, Alt JR, Wang P.
    Oncogene; 2004 Nov 25; 23(55):8931-40. PubMed ID: 15467748
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MIF loss impairs Myc-induced lymphomagenesis.
    Talos F, Mena P, Fingerle-Rowson G, Moll U, Petrenko O.
    Cell Death Differ; 2005 Oct 25; 12(10):1319-28. PubMed ID: 15947793
    [Abstract] [Full Text] [Related]

  • 6. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.
    Rounbehler RJ, Rogers PM, Conti CJ, Johnson DG.
    Cancer Res; 2002 Jun 01; 62(11):3276-81. PubMed ID: 12036945
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.
    Shreeram S, Hee WK, Demidov ON, Kek C, Yamaguchi H, Fornace AJ, Anderson CW, Appella E, Bulavin DV.
    J Exp Med; 2006 Dec 25; 203(13):2793-9. PubMed ID: 17158963
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
    Eischen CM, Roussel MF, Korsmeyer SJ, Cleveland JL.
    Mol Cell Biol; 2001 Nov 25; 21(22):7653-62. PubMed ID: 11604501
    [Abstract] [Full Text] [Related]

  • 11. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.
    Nilsson JA, Keller UB, Baudino TA, Yang C, Norton S, Old JA, Nilsson LM, Neale G, Kramer DL, Porter CW, Cleveland JL.
    Cancer Cell; 2005 May 25; 7(5):433-44. PubMed ID: 15894264
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA, Lemmer ER, Omori M, Wirth PJ, Factor VM, Thorgeirsson SS.
    Oncogene; 2000 Oct 19; 19(44):5054-62. PubMed ID: 11042693
    [Abstract] [Full Text] [Related]

  • 16. EBV latent membrane protein 2A orchestrates p27kip1 degradation via Cks1 to accelerate MYC-driven lymphoma in mice.
    Fish K, Sora RP, Schaller SJ, Longnecker R, Ikeda M.
    Blood; 2017 Dec 07; 130(23):2516-2526. PubMed ID: 29074502
    [Abstract] [Full Text] [Related]

  • 17. Phosphorylation of p53 serine 18 upregulates apoptosis to suppress Myc-induced tumorigenesis.
    Sluss HK, Gannon H, Coles AH, Shen Q, Eischen CM, Jones SN.
    Mol Cancer Res; 2010 Feb 07; 8(2):216-22. PubMed ID: 20145032
    [Abstract] [Full Text] [Related]

  • 18. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
    Meng X, Carlson NR, Dong J, Zhang Y.
    Oncogene; 2015 Nov 12; 34(46):5709-17. PubMed ID: 25823025
    [Abstract] [Full Text] [Related]

  • 19. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
    Santoni-Rugiu E, Duro D, Farkas T, Mathiasen IS, Jäättelä M, Bartek J, Lukas J.
    Oncogene; 2002 Sep 19; 21(42):6498-509. PubMed ID: 12226753
    [Abstract] [Full Text] [Related]

  • 20. Myc lacks E2F1's ability to suppress skin carcinogenesis.
    Rounbehler RJ, Schneider-Broussard R, Conti CJ, Johnson DG.
    Oncogene; 2001 Aug 30; 20(38):5341-9. PubMed ID: 11536046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.